Emerging Vaccine Technologies

GettyImages-1284041821 asian vaccine

Vaccines that use protein subunits or recombinant vectors are now the most common types of vaccines in development for infectious diseases and cancer, as they are relatively easy to produce and can be tailored to target specific antigens. Other types of vaccines, such as inactivated organisms, toxoids, conjugates, and genetic vaccines (mRNA, DNA), are also available, but each has its own unique development and manufacturing requirements. Rapidly shifting modalities require broad CDMO expertise and capacity.

Commercializing recombinant vector vaccines requires a skill set that differs from protein or peptide based approaches. A CDMO should be prepared to support the client’s vector selection or to suggest one from their own portfolio. FUJIFILM Diosynth Biotechnologies has broad and deep experience with virus and viral vector production, plus the analytical expertise to ensure drug product quality and potency at a range of production scales.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma

FUJIFILM Diosynth Biotechnologies